NCT01928420View on ClinicalTrials.gov

A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Alzheimer's DiseaseDementia
Interventions
DRUG

Drug: NIC5-15

A natural product, found in many foods and plants with mild insulin sensitizing effects

DRUG

Placebo

Subjects with Alzheimer's Disease placebo comparator

Trial Locations (1)

10468

James J Peters Veterans Affairs Medical Center, The Bronx

Sponsors
All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

collaborator

James J. Peters Veterans Affairs Medical Center

FED

lead

Humanetics Corporation

INDUSTRY

NCT01928420 - A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease | Biotech Hunter | Biotech Hunter